Novartis this week announced the launch of the Greater Manchester (UK) Future of Health Challenge and named the start-up businesses selected to participate. The intensive 12-week program will include training, mentoring, and support from leaders in the health and technology space to create new clinical solutions for patients in Greater Manchester and beyond. Fifteen participants were selected from over 100 applicants who replied to the call for creative use of new technologies to solve some of Greater Manchester’s most pressing health problems. In addition to access to world-class support and expertise, participating start-up companies also have a chance to receive cloud space and additional expert support from Google Cloud for Startups. Developmental projects entering the program range from advanced visualization software and tools to help improve cognition, to home-based care systems that support elderly independent living and a remote thermometer which requires no contact with the patient. The program asked applicant health technology start-ups and entrepreneurs to submit ideas that could be beneficial to one or more of three focus areas as selected by local health leaders: • Solutions that improve the experience of those with Dementia and/or Frailty. • Solutions allowing primary care and outpatient services to be delivered in or near the home for patients. • Innovations to allow Digital Nudges to improve Prevention and Public Health. The program's fifteen participants are:
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.